Numerous positive sides of IHL :
1. Once licences granted, Impression will become one of Australia’s first licensed distributors of medicinal cannabis products,
2. Have the ability to import, store, distribute and export medicinal cannabis products from its laboratory and manufacturing facility in Melbourne, Australia.
3. US Collaboration - already struck a deal with US-based cannabis supplier AXIM Biotechnologies, a company that has developed a plethora of cannabis-derived products.
AXIM is a leading cannabinoid biotech company that develops and manufactures products for a wide variety of intended purposes including the world’s first patented CBD-infused chewing gum with various strengths for the treatment of a range of indications, including pain related to Multiple Sclerosis.
https://*********.com.au/impression-healthcare-prepares-medical-cannabis-market-launch/
- Forums
- ASX - By Stock
- IHL
- Ann: Medicinal Cannabis Product Licensing Applications
Ann: Medicinal Cannabis Product Licensing Applications, page-44
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online